David L. Palchak
Expertise in
9
conditions

Dr. David L. Palchak

Hematology | Oncology
Pcr Oncology
Arroyo Grande, CA 
Accepting New Patients
Offers Telehealth
Expertise in
9
conditions
Pcr Oncology
Arroyo Grande, CA 

Overview

Dr. Palchak has bachelor's and master's degrees in biology from UC Irvine. He received his doctorate in medicine from St. Louis University, did a residency in internal medicine at Cottage Hospital in Santa Barbara, then medical oncology fellowship at UC San Diego. He established an independent medical oncology practice in Arroyo Grande in 1994 and has practiced continuously in the south county since that date. He established the region's first cancer research program, first tumor board, first nonprofit to expand services for cancer patients in our community among many other firsts.Respect the patient's wishes and treat others as we wish to be treated.

Dr. Palchak is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), Anemia, and Bone Marrow Aspiration.

Dr. Palchak is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. He is actively involved in clinical research, participating in 2 clinical trials. Dr. Palchak is currently accepting new patients.

Graduate Institution

Saint Louis University School Of Medicine

Specialties

Hematology
Oncology

Licenses

Internal Medicine in CA

Board Certifications

Internal Medicine (Sub: Medical Oncology)
Internal Medicine

Fellowships

UCSD Hemacology Oncology Fellowship

Hospital Affiliations

Adventist Health Sierra Vista
French Hospital Medical Center
Marian Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Pcr Oncology
Arroyo Grande, CA 93420

Additional Areas of Focus

Dr. Palchak has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drugs: Ribociclib, Letrozole, Goserelin, Leuprolide
Study Phase: Phase 3
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial
Similar Doctors
Expertise in
45
conditions
Dr. Brian A. Di Carlo
Hematology | Oncology
Expertise in
45
conditions
Dr. Brian A. Di Carlo
Hematology | Oncology
Referral may be required
Before you request

UCLA Health Hematology Oncology

892 Aerovista Pl, Ste 240, 
San Luis Obispo, CA 
 (8.2 miles away)
805-541-8252
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Di Carlo is a Hematologist and an Oncologist practicing medicine in San Luis Obispo, California. Dr. Di Carlo is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Paget Disease of the Breast, Lung Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Di Carlo is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine (Sub: Hematology). Dr. Di Carlo is currently accepting new patients.

Expertise in
17
conditions
Dr. Robert A. Dichmann
Hematology | Oncology
Expertise in
17
conditions
Dr. Robert A. Dichmann
Hematology | Oncology
Referral may be required

Central Coast Medical Oncology Corp

1325 E Church St Ste 301, 
Santa Maria, CA 
 (24.0 miles away)
805-349-9393
Languages Spoken:
English
See accepted insurances

Robert Dichmann is a Hematologist and an Oncologist practicing medicine in Santa Maria, California. Dr. Dichmann is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Pleuropulmonary Blastoma.

Expertise in
12
conditions
Dr. Deborah J. Villa
Hematology | Oncology
Expertise in
12
conditions
Dr. Deborah J. Villa
Hematology | Oncology
Referral may be required
Before you request

UCLA Health Hematology Oncology

892 Aerovista Pl, Ste 240, 
San Luis Obispo, CA 
 (8.2 miles away)
805-541-8252
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Deborah Villa is a Hematologist and an Oncologist practicing medicine in San Luis Obispo, California. Dr. Villa is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Melanoma. Dr. Villa is board certified in Internal Medicine (Sub: Medical Oncology). Dr. Villa is currently accepting new patients.

Frequently Asked Questions about Dr. David L. Palchak

Is Dr. David L. Palchak a top-rated expert for Schnitzler Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David L. Palchak is classified as an Distinguished expert for Schnitzler Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David L. Palchak specialize in?

While Dr. David L. Palchak is a Hematology, they have specific expertise in Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Chronic Lymphocytic Leukemia (CLL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. David L. Palchak accept my insurance?

Dr. David L. Palchak accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Palchak's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile